ArticleScientific reports2025
Critical role of the CMGC insert sequence for tyrosine autophosphorylation in the protein kinase DYRK1B.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrative Insights Into DYRK1A From Molecular Function to Therapeutic Advancement.Chemical biology & drug design · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many CMGC group kinases require phosphorylation of a conserved tyrosine residue in the activation loop to achieve catalytic activity. DYRK family members use a distinctive mechanism involving constitutive cis-autophosphorylation of this tyrosine. The structural basis of this process has remained unclear, as it occurs while the kinase is still in an inactive conformation, and the tyrosine does not match the known substrate consensus of DYRKs. Here, we exploited the different autophosphorylation capacities of the paralogs DYRK1A and DYRK1B to define structural determinants of this process. DYRK1A efficiently autophosphorylates even in cell-free systems, whereas DYRK1B does not. Using domain swaps and point mutations, we identify the CMGC insert in the C-terminal lobe and two adjacent proline residues (P332/P333 in DYRK1B) as critical for proper folding and activation. Mutation of either proline impaired DYRK1B autophosphorylation and nuclear localization but had no effect in DYRK1A. Substitution of the DYRK1B CMGC insert with that of DYRK1A rescued the maturation defect, demonstrating functional interplay between the insert and flanking prolines. Furthermore, the pathogenic R349W mutation in DYRK1B, associated with monogenic obesity and type 2 diabetes, also disrupted autophosphorylation. These findings highlight the role of the CMGC insert and adjacent prolines in DYRK kinase maturation and autoactivation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.